You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

CLINICAL TRIALS PROFILE FOR FENOFIBRATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for fenofibrate

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000620 ↗	Action to Control Cardiovascular Risk in Diabetes (ACCORD)	Completed	Centers for Disease Control and Prevention	Phase 3	1999-09-01	The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 ↗	Action to Control Cardiovascular Risk in Diabetes (ACCORD)	Completed	National Eye Institute (NEI)	Phase 3	1999-09-01	The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 ↗	Action to Control Cardiovascular Risk in Diabetes (ACCORD)	Completed	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Phase 3	1999-09-01	The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 ↗	Action to Control Cardiovascular Risk in Diabetes (ACCORD)	Completed	National Institute on Aging (NIA)	Phase 3	1999-09-01	The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 ↗	Action to Control Cardiovascular Risk in Diabetes (ACCORD)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	1999-09-01	The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for fenofibrate

Condition Name

Chart
Table

Condition Name for fenofibrate
Intervention	Trials
Dyslipidemia	24
Hypertriglyceridemia	19
Hyperlipidemia	15
Hypercholesterolemia	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for fenofibrate
Intervention	Trials
Dyslipidemias	44
Hyperlipidemias	28
Hypertriglyceridemia	25
Hyperlipoproteinemias	23
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for fenofibrate

Trials by Country

Map
Table

Trials by Country for fenofibrate
Location	Trials
United States	435
Canada	26
Germany	23
France	15
Poland	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for fenofibrate
Location	Trials
Florida	25
Texas	23
California	23
Illinois	20
Tennessee	20
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for fenofibrate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for fenofibrate
Clinical Trial Phase	Trials
Phase 4	37
Phase 3	43
Phase 2/Phase 3	11
[disabled in preview]	40
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for fenofibrate
Clinical Trial Phase	Trials
Completed	116
Terminated	17
Recruiting	16
[disabled in preview]	22
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for fenofibrate

Sponsor Name

Chart
Table

Sponsor Name for fenofibrate
Sponsor	Trials
Solvay Pharmaceuticals	17
Abbott	10
Merck Sharp & Dohme Corp.	8
[disabled in preview]	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for fenofibrate
Sponsor	Trials
Other	145
Industry	109
NIH	27
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.